
Kathryn Ruddy
Professor of Oncology · Mayo Clinic College of Medicine and Science
Credentials: · · · ·
History
- 2006–2008
Medical Oncology and Hematology Dana-Farber Cancer Institute
Research
Review · Nature Reviews Disease Primers · 2019 · 2,279 citations
Association analysis identifies 65 new breast cancer risk loci
Nature · 2017 · 1,113 citations
Journal of Clinical Oncology · 2017 · 1,017 citations

111 papers
- CL
59 papers

56 papers

55 papers

53 papers

35 papers

32 papers · 8 as a fellow

31 papers
Grants
- 2019–2027
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial
National Cancer Institute · R01
PI · $4.3M · Mayo Clinic Rochester
- 2022–2027
Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)
National Cancer Institute · R01
PI · $3M · Mayo Clinic Jacksonville
- 2014–2021
Synergizing Genome Sequencing with Advances in Patient Reprted Outcomes (PRO)
National Institute of Nursing Research · R01
Contact PI · $1.2M · Mayo Clinic Rochester
Clinical trials
- 2023–2027
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Principal investigator · Recruiting · Phase 2
Mayo Clinic
- 2017–2026
Principal investigator · Active not recruiting · Phase 2
Academic and Community Cancer Research United
- 2006–2035
The Young Women's Breast Cancer Study
Principal investigator · Active not recruiting
Dana-Farber Cancer Institute
- 2019–2022
Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
Study chair · Terminated · Phase 3
Alliance for Clinical Trials in Oncology




